All In Biotech

Drug Trial Radar · NCT06717438

Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])

A Phase 2 Randomized, Double-blind, Placebo-controlled, Study of Zatolmilast (BPN14770) in Subjects With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome)

Last checked: Nov 19, 2026Latest source record: Jun 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

30

Actual

Start

May 13, 2025

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
ShionogiIndustry
Sponsor type
Industry
First posted
Dec 5, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 9 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to assess the efficacy, safety, and tolerability of BPN14770 in participants aged 9 to 45 years with JS.

Conditions

  • Jordan's Syndrome
  • PPP2R5D Neurodevelopmental Disorder

Interventions

  • BPN14770Drug

    Capsules for oral administration

  • PlaceboDrug

    Capsules for oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline at Week 24 in Numerical Rating Scale Within the Domain of Language/CommunicationTime frame: Baseline, Week 24
  2. Number of Participants with Treatment-emergent Adverse Events (TEAEs)Time frame: Day 1 up to Week 96
  3. Discontinuation-emergent Signs and Symptoms (DESS) Questionnaire ScoreTime frame: Week 98
  4. Number of Participants with SeizuresTime frame: Up to Week 96
  5. Number of Participants at Suicidality RiskTime frame: Up to Week 96

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Rush University Medical Center

    Chicago, Illinois

  • Boston Children's Hospital

    Boston, Massachusetts

  • Seattle Children's Hospital

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.